Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting rights excluding treasury shares. This update is part of regulatory compliance under French financial market rules and provides transparency on shareholder voting power. Investors can use this information to assess their influence in company decisions.
Kering's monthly statement shows 123,420,778 total shares and 176,815,752 theoretical voting rights as of October 15, 2026. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 17, 2026 01:01 WIB: of 134 priced US stocks, 35 rose and 97 fell. Notable movers include MBLY at USD 7.08 with a 1-day change of -4.71% and Pluang order activity of 38% Sell / 62% Buy, TDUP at USD 2.25 down 4.26% with 100% Sell orders, and GME at USD 26.94 down 3.85% with 85% Sell orders.
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...
